Peer Review reports
From: Linaclotide for the treatment of refractory lower bowel manifestations of systemic sclerosis
| Original Submission | ||
|---|---|---|
| 27 Sep 2020 | Submitted | Original manuscript |
| 30 Oct 2020 | Reviewed | Reviewer Report |
| 17 Nov 2020 | Reviewed | Reviewer Report |
| 5 Feb 2021 | Author responded | Author comments - Eric Dein |
| Resubmission - Version 2 | ||
| 5 Feb 2021 | Submitted | Manuscript version 2 |
| 11 Feb 2021 | Reviewed | Reviewer Report |
| 25 Mar 2021 | Author responded | Author comments - Eric Dein |
| Resubmission - Version 3 | ||
| 25 Mar 2021 | Submitted | Manuscript version 3 |
| Publishing | ||
| 29 Mar 2021 | Editorially accepted | |
| 15 Apr 2021 | Article published | 10.1186/s12876-021-01738-0 |
You can find further information about peer review here.